Navigation Links
ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
Date:10/8/2009

UroCare; the dependence by ProUroCare on third parties for the development and manufacture of its products; and other risks and uncertainties detailed from time to time in ProUroCare's filings with the Securities and Exchange Commission including its most recently filed Form 10-K and Form 10-Q. ProUroCare undertakes no duty to update any of these forward-looking statements.

SOURCE ProUroCare Medical, Inc.


'/>"/>
SOURCE ProUroCare Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ProUroCare Medical Inc. Announces Pricing of Equity Offering
2. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Globus Medical Raises $110 Million in Series E Financing Round
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Boston University Biomedical Engineers Find Chink in Bacterias Armor
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... ,, Reportlinker.com announces that a ... its catalogue: ,, Hepatitis B Vaccines ... 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, ... Market Forecasts to 2015 ,, Summary ... new report, "Hepatitis B Vaccines - Pipeline ...
(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, Boehringer Ingelheim GmbH: ... ,, Introduction ,, This analysis ... Boehringer Ingelheim in the Rx pharmaceutical sector. ... pipeline analysis and assessment of financial performance, ...
(Date:12/15/2009)... 15 Waters Corporation (NYSE: ... (v.7.1 SR4), an electronic laboratory notebook solution for ... secure electronic repository that stores and manages all ... and is used to boost efficiency in life ... SAFE-BioPharma digital identity and signature standard. The SAFE-BioPharma ...
Breaking Medicine Technology:Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6China Yongxin Pharmaceuticals Inc to Distribute Medicines on the Essential Drug List 14997 1China Yongxin Pharmaceuticals Inc to Distribute Medicines on the Essential Drug List 14997 2China Yongxin Pharmaceuticals Inc to Distribute Medicines on the Essential Drug List 14997 3FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 1FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 2FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 3FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 4Facial Injectables Emerge From the Recession 6587 1Facial Injectables Emerge From the Recession 6587 2Facial Injectables Emerge From the Recession 6587 3
... ASCO Showed Acceptable Tolerability Profile, ... Low Incidence of Grade 3 and 4 Neuropathy, ... eribulin mesylate (E7389) demonstrated activity in a,heavily pretreated population ... to results of a multi-center Phase II clinical,trial. The ...
... N.J., May 15 Sanofi-aventis,(EURONEXT: SAN and ... the,landmark ATHENA study showed Multaq(R) (dronedarone), a ... atrial fibrillation or atrial flutter,decreased the risk ... by a statistically significant 24% (p=0.00000002), meeting ...
Other Medicine Technology:Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7
(Date:12/15/2009)... 15 Accelify is proud to announce the ... Advisors. David will serve as Director of Development in ... National Board of Advisors. ,, David Tokofsky ... Board of Education in June 1995. As the Board ... over 600,000 stretching from Northeast Los Angeles through East ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Diseases Therapeutics - Market Forecasts to ... Deals Analysis ,, http://www.reportlinker.com/p0168098/The-Future-of-Cardiovascular-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...
(Date:12/15/2009)... and CHENNAI, India, Dec. 15 ... the world leader in generic injectable pharmaceuticals, ... 524372, NSE: ORCHIDCHEM), a leading Indian pharmaceuticals ... antibiotics manufacturers globally, today announced an agreement ... finished-dosage form pharmaceuticals business for approximately $400 ...
(Date:12/15/2009)... Visits to a gynaecologist or midwife are generally ... but could offer so much more. Women, doctors ... great opportunities for dialogue about sexual health, reveals ... University of Gothenburg, Sweden. , Many young women ... Almost 500 women aged 23-29 answered questions about ...
(Date:12/15/2009)... BOSTON (December 15, 2009) Although seen as ... cholesterol levels by inhibiting activity of a transfer protein ... at the Jean Mayer USDA Human Nutrition Research Center ... Boston University School of Medicine found an association between ... increased risk of heart disease in the Framingham Heart ...
Breaking Medicine News(10 mins):Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 2Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 3Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 4Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 5Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 6Health News:More about sex and relationships needed at gynecological visits 2Health News:Low cholesterol transfer protein activity associated with heart disease risk 2
... 4 People who eat out,tend to consume more ... prefer takeout to the kitchen also tend to consume ... body needs to stay healthy. (Photo: http://www.newscom.com/cgi-bin/prnh/20071004/NYTHFNS2 ... said Peggy Fleming, Olympic figure,skating champion and HealthSaver spokesperson. ...
... EpiCept Corporation,(Nasdaq and OMX Nordic Exchange: EPCT) ... be presenting at the 2007 BIO InvestorForum on,October ... the Palace Hotel in San,Francisco, California. Mr. Talley ... http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO ) The presentation will be ...
... Oct. 3 Pam Brady,President of the California ... veto of federal legislation to expand the State,Children,s ... veto this morning of legislation to expand the ... children and families,including approximately 800,000 in California, who ...
... WASHINGTON, Oct. 3 Congressman Chaka Fattah,(D- PA) ... Child Health,Insurance Program. "The numbers just don,t ... $190,billion for the war, but he won,t support ... poor children. Quality health insurance is vital to ...
... A new Web site from Northwood,Health Systems has won ... five-year development effort in partnership with the best,Web designers ... the,application of Web site technology," Northwood President and Chief,Executive ... offers more than 1,000 accredited,continuing education courses for ...
... Mediware Information,Systems, Inc., (Nasdaq: MEDW ) announced ... notified the company regarding the company,s,non-compliance with Nadsaq ... the company,s audit committee. This issue arose,due to ... as an audit,committee member. On October 2, ...
Other Medicine News:Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Cook Your Way to a Healthy Diet 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Cook Your Way to a Healthy Diet 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Cook Your Way to a Healthy Diet 4Health News:EpiCept Corporation to Present at the 2007 BIO InvestorForum 2Health News:EpiCept Corporation to Present at the 2007 BIO InvestorForum 3Health News:Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market 2
Super High Density, multi-frequency, convex array, small footprint transducer for scanning during craniotomies....
This unique tiny transducer can be very helpful in tight situations like during a carotid endardarectomy procedure....
... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...
... Hemispheric Sound Technology, multi-frequency, linear ... transducer is very helpful in ... to be a choice transducer ... scanning. Its high frequency upper ...
Medicine Products: